Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1350.20

11.70 (0.87%)

< Home < Back

Dr. Reddys Laboratories informs about company updates

Date: 16-09-2017

Dr. Reddys Laboratories has informed about audit of API Mirfield Plant, United Kingdom, by the US FDA.

The above information is a part of company’s filings submitted to BSE.